156 case summaries of the patients who underwent excision of atrial myxomas at our institution from 2001 to 2013 are recruited to this retrospective analytical study.

1.To define ideal anesthetic technique for atrial myxomas 2. To update on monitoring and management of complications

Preoperative work up, associated co-morbid lesions such as PAH, CAD,CHD etc, intra operative and postoperative management are analyzed.

Atrial myxomas are the most common (50% of all primary cardiac tumors) benign primary tumours of the heart and sudden deaths probably related to coronary embolization have been described. Most often a thorough preoperative evaluation detects the underlying pathology in these asymptomatic patients when they undergo incidental non cardiac or cardiac surgery. Awareness of the clinical signs and symptoms produced by myxomas is essential to raise the suspicion of their presence. Atrial myxomas can produce obstructive, constitutional, and embolic symptoms when they weigh greater than 70 gms. Careful positioning for induction of anaesthesia is required, since patient's position can affect oxygenation. Anesthetic agents are to be titrated to the tailoring needs based on micro and macro-hemodynamics. cardiac intensive care involving extended ventilatory therapy in PAH and patients' with pulmonary embolic episodes also equally plays a pivotal role in the outcomes of cardiac myxomas' surgeries.